Four-drug attack on aggressive breast cancer shows promise in new trial
NCT ID NCT06027268
Summary
This study is testing whether combining four different cancer drugs works better against advanced triple-negative breast cancer, which is particularly hard to treat. The trial will enroll 36 patients to see if this combination can shrink tumors and control the disease while being safe enough for patients to tolerate. Researchers will track how well the treatment works and monitor side effects over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
Conditions
Explore the condition pages connected to this study.